These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3140770)

  • 1. Immunological characterization of plasminogen activators in human parotid saliva.
    Kjaeldgaard M; Kjaeldgaard A
    Arch Oral Biol; 1987; 32(12):855-7. PubMed ID: 3140770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological characterization of plasminogen activators in human mixed saliva.
    Kjaeldgaard A; Kjaeldgaard M
    Acta Physiol Scand; 1986 Mar; 126(3):443-7. PubMed ID: 3515850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of a fast-acting specific inhibitor of plasminogen activator in human parotid saliva.
    Kjaeldgaard A; Kjaeldgaard M; Gaffney P
    Acta Physiol Scand; 1989 Nov; 137(3):379-83. PubMed ID: 2512768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of plasminogen activators in unstimulated and stimulated human whole saliva.
    Sindet-Pedersen S; Gram J; Jespersen J
    J Dent Res; 1987 Jun; 66(6):1199-203. PubMed ID: 3114346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of flow rate on tissue plasminogen activator activity in human parotid saliva.
    Kjaeldgaard M; Lagerlöf F; Kjaeldgaard A
    Arch Oral Biol; 1989; 34(8):621-3. PubMed ID: 2512904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of tissue plasminogen activators and urokinase by human saliva.
    Haze C; Garfunkel AA; Eldor A; Kadouri A
    Oral Surg Oral Med Oral Pathol; 1994 Apr; 77(4):356-61. PubMed ID: 8015799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The possible role of oral epithelial cells in tissue-type plasminogen activator-related fibrinolysis in human saliva.
    Sindet-Pedersen S; Gram J; Jespersen J
    J Dent Res; 1990 Jun; 69(6):1283-6. PubMed ID: 2113068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological characterization of plasminogen activator activities in human tissues and body fluids.
    Rijken DC; Wijngaards G; Welbergen J
    J Lab Clin Med; 1981 Apr; 97(4):477-86. PubMed ID: 6782183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
    Camiolo SM; Greco WR
    Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical localization of urokinase- and tissue-type plasminogen activators in psoriatic skin.
    Grøndahl-Hansen J; Ralfkiaer E; Nielsen LS; Kristensen P; Frentz G; Danø K
    J Invest Dermatol; 1987 Jan; 88(1):28-32. PubMed ID: 3098860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological comparison between human and rat plasminogen activators in blood and the vessel wall.
    Kjaeldgaard A; Larsson B; Astedt B
    J Clin Pathol; 1984 Oct; 37(10):1153-6. PubMed ID: 6541663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological identification of plasminogen activators in normal and malignant tissues of the oral cavity in man.
    Ljungnér H; Björlin G; Astedt B
    Int J Oral Surg; 1984 Aug; 13(4):334-8. PubMed ID: 6434453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human seminal fibrinolytic activity: specific determinations of tissue plasminogen activator and urokinase.
    Van Dreden P; Gonzalès J; Poirot C
    Andrologia; 1991; 23(1):29-33. PubMed ID: 1910268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological characterisation of plasminogen activators in the human vessel wall.
    Ljungnér H; Holmberg L; Kjeldgaard A; Nilsson IM; Astedt B
    J Clin Pathol; 1983 Sep; 36(9):1046-9. PubMed ID: 6684128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of plasminogen activator activity in the intima and media of the normal human aorta and other large arteries: immunological identification of the plasminogen activator(s).
    Smokovitis AA; Kokolis NA; Alexaki E; Binder BR
    Thromb Res; 1989 Jul; 55(2):259-65. PubMed ID: 2528844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activators in alveolar bone in man.
    Björlin G; Ljungnér H; Astedt B
    Acta Odontol Scand; 1986 Jun; 44(3):173-5. PubMed ID: 3461663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical properties of conjugates of urokinase-type plasminogen activator with a monoclonal antibody specific for cross-linked fibrin.
    Dewerchin M; Lijnen HR; Van Hoef B; De Cock F; Collen D
    Eur J Biochem; 1989 Oct; 185(1):141-9. PubMed ID: 2530085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non neutralizing antibodies to tissue type plasminogen activator in the serum of acute myocardial infarction patients treated with the recombinant protein.
    Cugno M; Cicardi M; Colucci M; Bisiani G; Merlini PA; Spinola A; Paonessa R; Agostoni A
    Thromb Haemost; 1996 Aug; 76(2):234-8. PubMed ID: 8865537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA).
    Nelles L; Lijnen HR; Van Nuffelen A; Demarsin E; Collen D
    Thromb Haemost; 1990 Aug; 64(1):53-60. PubMed ID: 2148847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization and immunological characterization of plasminogen activators in human prostate tissue.
    Kirchheimer J; Binder BR
    Haemostasis; 1983; 13(6):358-62. PubMed ID: 6199265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.